Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03933384
PHASE4

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Sponsor: Taichung Veterans General Hospital

View on ClinicalTrials.gov

Summary

To compare the efficacy and renal safety of tenofovir alafenamide (TAF) versus entecavir (ETV) in the chronic hepatitis B patients.

Official title: Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B: An Open Label, Randomized Controlled Trial

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2019-08-19

Completion Date

2030-12-31

Last Updated

2025-01-09

Healthy Volunteers

No

Interventions

DRUG

Tenofovir alafenamide

Tenofovir alafenamide 25mg/tab once daily

DRUG

Entecavir

Entecavir 0.5mg/tab once daily

Locations (1)

Taichung Veterans General Hospital

Taichung, Taichung, Taiwan